Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+106K
-
Total reported value, excl. options
-
$365M
-
Value change
-
+$4.13M
-
Number of buys
-
42
-
Number of sells
-
-65
-
Price
-
$17.86
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2017
125 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2017.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 46.4M outstanding shares and own 44.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.39M shares), VANGUARD GROUP INC (2.41M shares), DIMENSIONAL FUND ADVISORS LP (1.33M shares), Invesco Ltd. (1.33M shares), FEDERATED INVESTORS INC /PA/ (1.05M shares), STATE STREET CORP (969K shares), TEACHERS ADVISORS, LLC (549K shares), NORTHERN TRUST CORP (486K shares), Bank of New York Mellon Corp (479K shares), and JPMORGAN CHASE & CO (407K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.